impaired fasting glucose


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.
Related to impaired fasting glucose: prediabetes, Impaired glucose tolerance

impaired fasting glucose

Abbreviation: IFG
Abnormal glucose metabolism demonstrated by the presence of a fasting blood sugar that is greater than 100 mg/dl, but less than 126 mg/dL.
See also: glucose
References in periodicals archive ?
Comparing the hypertensive subjects with normal fasting glucose with those with impaired fasting glucose, the latter tended to have higher rates of hypertriglyceridaemia, hypo-HDL-cholesterolaemia, elevated LDL, hypercholesterolaemia and visceral obesity than those who had normal fasting glucose (Table II).
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.
After an overnight fast, the normal level is below 110 mg/dL If it is in the 110 to 125 mg/dL range, you have impaired fasting glucose or pre-diabetes.
The ADA defines impaired fasting glucose as a fasting plasma glucose of 5.
Survey design: A cross-sectional, single-center study was carried out between October 2007 and June 2008, in Fatih University Hospital, with 908 subjects who were admitted to our Internal Medicine, Gastroenterology and Endocrinology outpatient clinics without any known hypertension, diabetes mellitus, impaired fasting glucose and hyperlipidemia.
Current diagnostic criteria for the population in general--by which a fasting blood glucose level (FBG) of 126 mg/dL indicates diabetes and an FBG of 100-125 mg/dL indicates impaired fasting glucose or prediabetes--were set several years ago when it became apparent that the previous diagnostic threshold of 140 mg/dL was too high.
Fasting Plasma Glucose (FPG) or Impaired Fasting Glucose (IFG) is when fasting blood sugar levels are between 100 and 125 mg/dl (milligrams/deciliter) on at least two occasions.
About one in four adult Australians has abnormal glucose metabolism; 4% have diagnosed diabetes, 4% have undiagnosed diabetes and 16% have impaired glucose tolerance or impaired fasting glucose.
And nearly 40 percent of people ages 65 and older had impaired fasting glucose, a form of pre-diabetes.
Tesaglitazar reduced the prevalence of metabolic syndrome and impaired fasting glucose in an insulin-resistant, non-diabetic population.
A People with prediabetes are those found to have impaired glucose tolerance (IGT) or impaired fasting glucose (IFG).
Optimal first-step antihypertensive drug therapy in persons with type 2 diabetes mellitus (DM) or impaired fasting glucose (IFG) is uncertain.